GeoVax Marburg Vaccine Data Presented at the 23rd Annual World Vaccine Congress
| GOVX Stock | USD 2.44 0.01 0.41% |
Slightly above 64% of all GeoVax Labs' investors are looking to take a long position. The analysis of the overall investor sentiment regarding GeoVax Labs suggests that some traders are interested. GeoVax Labs' investing sentiment can be driven by a variety of factors including economic data, GeoVax Labs' earnings reports, geopolitical events, and overall market trends.
GeoVax |
80 percent Survival in Nonhuman Primates Observed in a Lethal Challenge Model Atlanta, GA, April 05, 2023 -- via NewMediaWire GeoVax Labs, Inc. , a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the presentation of encouraging data from recent nonhuman primate studies of GeoVaxs vaccine candidate against Marburg virus, during the 23rd Annual World Vaccine Congress taking place in Washing
Read at finance.yahoo.com
 |
GeoVax Labs Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards GeoVax Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
GeoVax Labs Fundamental Analysis
We analyze GeoVax Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeoVax Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeoVax Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
GeoVax Labs is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
GeoVax Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeoVax Labs stock to make a market-neutral strategy. Peer analysis of GeoVax Labs could also be used in its relative valuation, which is a method of valuing GeoVax Labs by comparing valuation metrics with similar companies.
Peers
GeoVax Labs Related Equities
| CDIO | Cardio Diagnostics | 40.74 | ||||
| QNRX | Quoin Pharmaceuticals | 5.48 | ||||
| ATNF | 180 Life | 3.83 | ||||
| CYTO | Altamira Therapeutics | 2.17 | ||||
| ZURA | Zura Bio | 0.72 | ||||
| OCGN | Ocugen | 1.14 | ||||
| ATXI | Avenue Therapeutics | 2.11 | ||||
| ZVSA | ZyVersa Therapeutics | 3.57 | ||||
| IBIO | Ibio | 3.62 | ||||
| PHIO | Phio Pharmaceuticals | 3.91 | ||||
| SONN | Sonnet Biotherapeutics | 5.24 | ||||
| REVB | Revelation Biosciences | 6.67 | ||||
| JAGX | Jaguar Animal | 18.75 |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.